Major Investor Insight Venture Partners Files Intent to Sell $9.3M in Hinge Health Stock
HNGE has more than doubled off its 52-week low of $30.08 on elevated volume (2.6× avg).
Summary
Major institutional investor Insight Venture Partners has filed to sell $9.3 million in Hinge Health stock, continuing a pattern of significant share dispositions.
Key Events · Ownership and Investor Activity · HNGE
-
Intent to Sell Shares
Insight Venture Partners, a 10% stockholder, filed a Form 144 to sell 116,183 shares of Class A Common Stock, valued at approximately $9.3 million.
-
Ongoing Share Distribution
This filing adds to a series of recent Form 144s from Insight Venture Partners, indicating a continued reduction of their stake in Hinge Health.
-
Trading Near 52-Week Highs
The proposed sale occurs while Hinge Health's stock is trading near its 52-week high of $84.62, suggesting the investor is locking in gains.
Analysis · HNGE · Technology
Insight Venture Partners, a 10% stockholder, continues to reduce its stake in Hinge Health by filing to sell an additional $9.3 million in shares. This follows several other large Form 144 filings by the same investor in recent weeks, indicating an ongoing distribution of shares while the stock trades near its 52-week high.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HNGE was trading at $81.00 on NYSE in the Technology sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $30.08 to $84.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.